GS
CRNX icon

GTS Securities’s Crinetics Pharmaceuticals CRNX Stock Holding History

GTS Securities’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– – – 1668
2024
Q1 		– Hold
0
– – – 1548
2023
Q4 		– Sell
-13,874
Closed -$413K – 1644
2023
Q3 		$413K Buy
+13,874
New +$413K ﹤0.01% 868